Clinical, imaging and genetic profile of twenty-four patients with pantothenate kinase-associated neurodegeneration (PKAN)- A single centre study from India

被引:2
|
作者
Sriram, Neeharika [1 ]
Holla, Vikram V. [1 ]
Kumari, Riyanka [2 ,3 ]
Kamble, Nitish [1 ]
Saini, Jitender [4 ]
Mahale, Rohan [1 ]
Netravathi, Manjunath [1 ]
Padmanabha, Hansashree [1 ]
Gowda, Vykuntaraju K. [5 ]
Battu, Rajani [6 ]
Pandey, Akhilesh [3 ,7 ,8 ]
Yadav, Ravi [1 ]
Muthusamy, Babylakshmi [2 ,3 ]
Pal, Pramod Kumar [1 ,9 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bengaluru 560029, India
[2] Inst Bioinformat, Int Technol Pk, Bengaluru 560066, India
[3] Manipal Acad Higher Educ, Manipal 576104, Karnataka, India
[4] Natl Inst Mental Hlth & Neurosci, Neuroimaging & Intervent Radiol, Bengaluru 560029, India
[5] Indira Gandhi Inst Child Hlth, Dept Paediat Neurol, Bengaluru 560029, India
[6] Ctr Eye Genet & Res, Bangalore, India
[7] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[8] Mayo Clin, Ctr Individualized Med, Rochester, MN USA
[9] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Hosur Rd, Bengaluru 560029, Karnataka, India
关键词
Pantothenate kinase-associated neuro; degeneration; Retinitis pigmentosa; Movement disorders; Eye -of -the -tiger sign; BRAIN IRON ACCUMULATION; TIGER SIGN; PANK2; DYSTONIA; MUTATION; EYE;
D O I
10.1016/j.parkreldis.2023.105409
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Pantothenate kinase-associated neurodegeneration (PKAN) is the most common "Neuro-degeneration with Brain Iron Accumulation" disorder. This study aimed to study the clinical, radiological and genetic profiling of a large cohort of patients with PKAN.Methods: This is an ambispective hospital-based single centre study conducted at a tertiary care centre from India. After tabulating the clinical details, appropriate rating scales were applied followed by magnetic resonance imaging brain and exome sequencing. The segregation of the causal variants in the families were analysed using Sanger sequencing.Results: Twenty-four patients (14 males) with a median age at initial examination of 13 years (range: 4-54 years) and age at onset of 8 years (range: 0.5-40 years) were identified. Almost two-thirds (62%) had onset before 10 years. Difficulty walking was the most common presenting symptom (41.6%) and dystonia was the most common extrapyramidal phenomenology (100%) followed by parkinsonism (54.2%). Retinitis pigmentosa was present in 37.5% patients. MRI showed hypo intensity on T2 and SWI sequences in globus pallidus (100%), substantia nigra (70.8%) and red nucleus (12.5%). Eye-of-the-tiger sign was present in 95.8%. Biallelic variants in PANK2 gene was identified in all 20 patients who underwent genetic testing. Among the 18 unique variants identified in these 20 patients 10 were novel. Sanger sequencing confirmed the segregation of the mutation in the available family members.Conclusions: Wide range of age at onset was noted. Dystonia at presentation, pathognomonic eye-of-tiger sign, and disease-causing variants in PANK2 gene were identified in nearly all patients. Ten novel variants were identified expanding the genotypic spectrum of PKAN.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical heterogeneity of pantothenate kinase-associated neurodegeneration (PKAN)
    Thomas, M
    Hayflick, SJ
    Jankovic, J
    NEUROLOGY, 2002, 58 (07) : A322 - A322
  • [2] Pantothenate kinase-associated neurodegeneration (PKAN) - a rare clinical entity
    Saha, Appas
    Shabnam, Srushti
    Swapna, N.
    ACTA OTO-LARYNGOLOGICA CASE REPORTS, 2016, 1 (01): : 90 - 97
  • [3] Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)
    Hogarth, Penelope
    Kurian, Manju A.
    Gregory, Allison
    Csanyi, Barbara
    Zagustin, Tamara
    Kmiec, Tomasz
    Wood, Patricia
    Klucken, Angelika
    Scalise, Natale
    Sofia, Francesca
    Klopstock, Thomas
    Zorzi, Giovanna
    Nardocci, Nardo
    Hayflick, Susan J.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (03) : 278 - 287
  • [4] Subthalamic Nuclei Stimulation in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Liu, Ziyuan
    Liu, Yang
    Yang, Yingmai
    Wang, Lin
    Dou, Wanchen
    Guo, Jinzhu
    Wang, Yu
    Guo, Yi
    Wan, Xinhua
    Ma, Wenbin
    Wang, Renzhi
    NEUROMODULATION, 2017, 20 (05): : 484 - 491
  • [5] Grey matter alterations in patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Rodriguez-Raecke, Rea
    Roa-Sanchez, Pedro
    Speckter, Herwin
    Fermin-Delgado, Rafael
    Perez-Then, Eddy
    Oviedo, Jairo
    Stoeter, Peter
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (09) : 975 - 979
  • [6] Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery
    Svetel, Marina
    Tomic, Aleksandra
    Dragasevic, Natasa
    Petrovic, Igor
    Kresojevic, Nikola
    Jech, Robert
    Urgosik, Dusan
    Banjac, Isidora
    Vitkovic, Jelena
    Novakovic, Ivana
    Kostic, Vladimir S.
    JOURNAL OF NEUROLOGY, 2019, 266 (12) : 2962 - 2969
  • [7] Pantothenate Kinase-Associated Neurodegeneration (PKAN) With Concomitant Blepharospasm: Unveiling a Clinical Enigma
    Reddy, Venkat
    Saboo, Keyur
    Reddy, Kavyanjali
    Kumar, Sunil
    Acharya, Sourya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [8] Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery
    Marina Svetel
    Aleksandra Tomić
    Nataša Dragašević
    Igor Petrović
    Nikola Kresojević
    Robert Jech
    Dušan Urgošik
    Isidora Banjac
    Jelena Vitković
    Ivana Novaković
    Vladimir S. Kostić
    Journal of Neurology, 2019, 266 : 2962 - 2969
  • [9] Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Greblikas, F.
    Jinnah, H. A.
    Klopstock, T.
    Videnovic, A.
    Burns, C.
    MOVEMENT DISORDERS, 2019, 34 : S210 - S210
  • [10] Changes of cerebral white matter in patients suffering from Pantothenate Kinase-Associated Neurodegeneration (PKAN): A diffusion tensor imaging (DTI) study
    Stoeter, P.
    Roa-Sanchez, P.
    Speckter, H.
    Perez-Then, E.
    Foerster, B.
    Vilchez, C.
    Oviedo, J.
    Rodriguez-Raecke, R.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (06) : 577 - 581